JP2014516530A - イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用 - Google Patents

イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用 Download PDF

Info

Publication number
JP2014516530A
JP2014516530A JP2014511717A JP2014511717A JP2014516530A JP 2014516530 A JP2014516530 A JP 2014516530A JP 2014511717 A JP2014511717 A JP 2014511717A JP 2014511717 A JP2014511717 A JP 2014511717A JP 2014516530 A JP2014516530 A JP 2014516530A
Authority
JP
Japan
Prior art keywords
virus
canine influenza
gene
seq
recombinant virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014511717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516530A5 (enExample
Inventor
ゼジュン リー，
チャオヤン テン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Veterinary Research Institute
Original Assignee
Shanghai Veterinary Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Veterinary Research Institute filed Critical Shanghai Veterinary Research Institute
Publication of JP2014516530A publication Critical patent/JP2014516530A/ja
Publication of JP2014516530A5 publication Critical patent/JP2014516530A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
JP2014511717A 2011-05-26 2012-04-26 イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用 Pending JP2014516530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2011101395283A CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用
CN201110139528.3 2011-05-26
PCT/CN2012/074722 WO2012159522A1 (zh) 2011-05-26 2012-04-26 犬流感重组病毒及其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2014516530A true JP2014516530A (ja) 2014-07-17
JP2014516530A5 JP2014516530A5 (enExample) 2015-04-23

Family

ID=44776999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511717A Pending JP2014516530A (ja) 2011-05-26 2012-04-26 イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用

Country Status (7)

Country Link
US (1) US20140286979A1 (enExample)
EP (1) EP2716752A4 (enExample)
JP (1) JP2014516530A (enExample)
KR (1) KR20140031912A (enExample)
CN (1) CN102220293B (enExample)
CA (1) CA2837126A1 (enExample)
WO (1) WO2012159522A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602697A (zh) * 2017-08-29 2018-01-19 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
KR101633489B1 (ko) 2015-02-25 2016-06-27 고패스 주식회사 통풍수단이 구비된 신발의 사출식 제조방법
NZ739260A (en) 2015-06-26 2019-09-27 Boehringer Ingelheim Animal Health Usa Inc Inactivated canine influenza vaccines and methods of making and uses thereof
CN105647877A (zh) * 2016-02-02 2016-06-08 南京农业大学 一株低毒力重组猪脑心肌炎病毒及其应用
CN113173976B (zh) * 2021-06-03 2022-07-12 北京市农林科学院 一种犬流感病毒h3亚型ha蛋白、其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1624116A (zh) * 2003-12-02 2005-06-08 中国农业科学院哈尔滨兽医研究所 人工重组的流感病毒及其应用
JP2011501950A (ja) * 2007-10-30 2011-01-20 バイオノートインコーポレイテッド 新規のイヌインフルエンザウイルス及びこのワクチン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1820853T3 (da) * 1999-04-06 2011-12-19 Wisconsin Alumni Res Found Rekombinant influenzavirus til vacciner og genterapi
US7384642B2 (en) * 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
EP2407480B1 (en) * 2005-10-19 2014-07-16 University of Florida Research Foundation, Incorporated Materials for respiratory disease control in canines
MX2010002729A (es) * 2007-09-10 2010-03-31 Intervet Int Bv Composiciones y metodos para prevenir infeccion de influenza en caninos, felinos y equinos.
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1624116A (zh) * 2003-12-02 2005-06-08 中国农业科学院哈尔滨兽医研究所 人工重组的流感病毒及其应用
JP2011501950A (ja) * 2007-10-30 2011-01-20 バイオノートインコーポレイテッド 新規のイヌインフルエンザウイルス及びこのワクチン

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6016009551; ＰＬｏＳ　Ｃｕｒｒ． Ｖｏｌ．２, 20100905, ＲＲＮ１１６５ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602697A (zh) * 2017-08-29 2018-01-19 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用
CN107602697B (zh) * 2017-08-29 2020-05-05 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用

Also Published As

Publication number Publication date
US20140286979A1 (en) 2014-09-25
CN102220293A (zh) 2011-10-19
CN102220293B (zh) 2012-12-19
KR20140031912A (ko) 2014-03-13
EP2716752A4 (en) 2014-04-30
CA2837126A1 (en) 2012-11-29
EP2716752A1 (en) 2014-04-09
WO2012159522A1 (zh) 2012-11-29

Similar Documents

Publication Publication Date Title
JP7829610B2 (ja) Ｍｄｃｋ、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス
CN115998856B (zh) 一种新冠流感免疫原性组合物及其制备方法和应用
US20140227310A1 (en) Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
CN103266090B (zh) Asia1型口蹄疫重组病毒及其制备方法和应用
US20140286979A1 (en) Canine influenza recombinant virus, preparation method therefor and application thereof
CN103627718B (zh) 表达ibv s1和n双抗原蛋白重组质粒及其构建方法和应用
CN108660118B (zh) 一种导致鸭关节炎的新型鸭呼肠孤病毒及其应用
CN105671002B (zh) H9n2亚型禽流感病毒细胞高产疫苗株构建及应用
CN102526718B (zh) 一种重组h5n1禽流感病毒细胞苗及应用
CN108602860B (zh) 通过去脂作用灭活病毒
CN104073470A (zh) 一种h9n2亚型禽流感病毒的转瓶培养方法
CN108498794B (zh) 一种防治新型鸭呼肠孤病毒的灭活疫苗及其制备方法
CN101293099B (zh) 一种抗多种亚型禽流感病毒的多肽疫苗及其制备方法
CN105985446B (zh) 可优化病毒复制的培养基
CN102864129A (zh) 高效表达ha蛋白的重组流感病毒及其制备方法和应用
CN102864128A (zh) 高效表达ha蛋白的重组流感病毒及其制备方法和应用
CN102190701B (zh) 一种流感病毒血凝素大规模分离纯化方法
CN102370976B (zh) 猪流感病毒和猪口蹄疫病毒的混合病毒样颗粒、制备方法和应用
CN110760616A (zh) 新城疫病毒和h9n2亚型禽流感病毒检测阳性标准品及其制备方法与应用
KR20130051799A (ko) 고생산성, 고면역원성, 및 무병원성 인플루엔자 바이러스 제작용 재조합 발현 벡터
CN102839160A (zh) 高效表达ha蛋白的重组流感病毒及其制备方法和应用
Duong et al. Expression and purification capsid proteins Vp0, Vp1 and Vp3 of foot and mouth disease virus type O in Escherichia coli
KR101414225B1 (ko) 발육계란 고증식성 인플루엔자 바이러스 제작용 재조합 발현 벡터
CN116814562A (zh) 基于目的基因S1的人5型复制缺陷型重组腺病毒、制备方法及用于预防SARS-CoV-2感染的疫苗
WO2024103579A1 (zh) 一种冠状病毒假病毒颗粒的制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160315

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161018